Germany wants to use Regeneron's Covid-19 antibody therapy more broadly
“The drug is available in Germany, we need it much more and we want it much more and we are working on rolling it out across the nation,” Health Minister Jens Spahn told a weekly news conference
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020/ Reuters
Germany would like to use Regeneron's Covid-19 monoclonal antibody cocktail as a treatment for this disease more broadly but needs to finalize some details on reimbursement, Health Minister Jens Spahn said on Thursday.
"The drug is available in Germany, we need it much more and we want it much more and we are working on rolling it out across the nation," he told a weekly news conference.
Keep updated, follow The Business Standard's Google news channel
